This ATG5 deficiency suppressed inflammation and airway fibrosis, similarly to what it was observed in ovalbumin-challenged mice with Ang-(1–7) administration, suggesting another mechanism for Ang-(1–7) as an asthma treatment (Xu et al., 2023). The gene discussed is ANGPT1; the disease is asthma.